BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 1290291)

  • 1. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].
    Meinertz T; Zehender M; Hohnloser SH
    Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antiarrhythmic agents: current situation].
    Bonhorst D
    Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arrhythmia and anti-arrhythmia therapy as prognostic risks].
    Meinertz T; Zehender M; Hofmann T; Hohnloser S; Just H
    Herz; 1991 Sep; 16 Spec No 1():314-7, 323. PubMed ID: 1820298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Value of experimental and clinical methods on the effectiveness and side effect profile of anti-arrhythmia agents].
    Kuck KH
    Z Kardiol; 1992; 81 Suppl 4():151-5. PubMed ID: 1283932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
    Zrenner B; Koller B; Rudolph W
    Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of ventricular arrhythmias: then and now.
    Bennett B; Singh S
    Am J Crit Care; 1992 Nov; 1(3):107-14. PubMed ID: 1307899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W; Borggrefe M; Block M; Böcker D; Breithardt G
    Z Kardiol; 1996; 85 Suppl 6():97-106. PubMed ID: 9064989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methodology in clinical trials of anti-arrhythmia agents in ventricular arrhythmias. Analysis and perspective following results of the CAST study].
    Jaillon P; Dupuis B
    Arch Mal Coeur Vaiss; 1991 Feb; 84 Spec No 2():35-40. PubMed ID: 1669238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and toxicity of antiarrhythmic drug therapy: benefit versus risk.
    Podrid PJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 6():S65-73. PubMed ID: 1723122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Philosophy of antiarrhythmic approaches to ventricular tachyarrhythmias close to the 21st century.
    Breithardt G; Haverkamp W; Böcker D; Borggrefe M
    Rev Port Cardiol; 1998 Dec; 17(12):981-91. PubMed ID: 9973859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sudden cardiac death--possibilities and limits of drug therapy].
    Manz M; Lüderitz B
    Z Kardiol; 1992 May; 81(5):237-45. PubMed ID: 1621403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
    Kellen JC; Ettinger A; Todd L; Brezsnyak ML; Campion J; McBride R; Thomas S; Corum J; Schron E
    Am J Crit Care; 1996 Jan; 5(1):19-25. PubMed ID: 8680488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cardiac arrhythmia suppression trial (CAST)].
    Furlanello F
    G Ital Cardiol; 1990 Feb; 20(2):171-6. PubMed ID: 2109715
    [No Abstract]   [Full Text] [Related]  

  • 15. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ventricular arrhythmias: diagnosis and drug therapy].
    Schüpfer C; Gertsch M
    Praxis (Bern 1994); 1996 May; 85(20):647-54. PubMed ID: 8685556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic therapy in heart failure.
    Eckardt L; Haverkamp W; Breithardt G
    Heart Fail Monit; 2002; 2(4):110-9. PubMed ID: 12634885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W; Wichter T; Chen X; Hördt M; Willems S; Rotman B; Hindricks G; Kottkamp H; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():75-85. PubMed ID: 7846949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
    Camm AJ; Kautzner J
    Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ventricular cardiac arrhythmias. New anti-arrhythmia agents].
    Scholz H
    Z Kardiol; 1996; 85 Suppl 6():91-6. PubMed ID: 9064988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.